Search clinical trials for: Observational Warfarin

Total 3055 results

Boryung Pharmaceutical Co., Ltd

Completed

A Clinical Trial to Evaluate the Effect of Fimarsartan on Pharmacodynamics, Pharmacokinetics, and the Safety of Warfarin in Healthy Male Volunteers

Essential Hypertension
Robert Pendleton
University of Louisville

Completed

Personalized Medicine Interface Tool (PerMIT): Warfarin: A Trial Comparing Usual Care Warfarin Initiation to PerMIT Pharmacogenetic Guided Warfarin Therapy (PerMIT)

Blood Clotting

United States
Boehringer Ingelheim

Completed

Bioequivalence of IVAX Warfarin Tablets and Coumadin Brand Warfarin Tablets in Healthy Volunteers

Healthy
Kartal Kosuyolu Yuksek Ihtisas Education and Research...

Unknown

Anticoagulation Regiments in Patients With Prosthetic Heart Valve Thrombosis

Thrombosis

Turkey
ARYx Therapeutics

Unknown

Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation (EmbraceAC)

Myocardial Infarction | Atrial Fibrillation | Atrial Flutter | Cardiomyopathy | Venous Thromboembolic Disease

United States
Pfizer
Medivation, Inc.

Completed

A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects

Alzheimer's Disease | Huntington's Disease

United States
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Drug Drug Interaciton Study of Imrecoxib and Warfarin in Healthy Volunteers

Knee Osteoarthritis

China
Chong Kun Dang Pharmaceutical

Completed

Drug-drug Interaction Study(Lobeglitazone, Warfarin)

Type 2 Diabetes Mellitus

Korea, Republic of
Wuhan Asia Heart Hospital

Unknown

AI-based Social Software to Manage wARfarin Therapy (AI-SMART)

Anticoagulant-induced Bleeding | Warfarin Sodium Causing Adverse Effects in Therapeutic Use

China
Medco Health Solutions, Inc.
Mayo Clinic; Washington University School of Medicine

Completed

The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings (MHSMayoWarf1)

Vascular Diseases | Embolism | Embolism and Thrombosis | Thrombosis | Thromboembolism | Venous Thromboembolism | Warfarin

United States
Novo Nordisk A/S

Completed

Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy Subjects

Healthy | Diabetes Mellitus, Type 2 | Diabetes

Germany
The First Affiliated Hospital with Nanjing Medical...

Completed

LAA Excision With AF Ablation Versus Oral Anticoagulants for Secondary Prevention of Stroke (5A)

Stroke | Atrial Fibrillation | Systemic Embolism

China
Children's Hospital of Fudan University

Completed

Peri-conception Key Nutritional Factors and Congenital Heart Disease (PKNFCHD)

Congenital Heart Disease

China
Astellas Pharma Global Development, Inc.
Basilea Pharmaceutica International Ltd

Completed

Drug Interaction Study of Isavuconazole and Warfarin in Healthy Male Subjects

Healthy Volunteers | Pharmacokinetics of Isavuconazole | Pharmacokinetics of S- and R-warfarin | Pharmacodynamics of Warfarin

United States
AstraZeneca

Completed

Interaction of Epanova on Warfarin Pharmacokinetic and Anticoagulant Activity and Comparison of the Effects of Epanova and Lovaza on Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) After Low-fat Meals

Hypertriglyceridemia

United States
University of Alberta

Completed

Evaluation of Maintenance Dosing vs Loading Dosing Upon Restarting Warfarin Therapy: A Prospective Randomized Trial

Anticoagulation

Canada
University of Idaho

Not yet recruiting

Early Life Feeding Exposure and Infant Immune and Health Status.

Maternal Behavior | Infant Development | Maternal Obesity | Breast Milk Collection

United States
Vista Klinik
University Hospital, Basel, Switzerland

Completed

Prevalence of DRP and DME Among Type 1 Diabetics Treated With Long-term Intensified Insulin Therapy

Insulin-Dependent Diabetes Mellitus 1

Switzerland
Vista Klinik
University Hospital, Zürich

Completed

Prevalence of DRP and DME Among Type 1 Diabetics Treated With Long-term Intensified Insulin Therapy

Insulin-Dependent Diabetes Mellitus 1

Switzerland
Pfizer

Withdrawn

The Effectiveness and Safety of Apixaban in NVAF Patients With History of Osteoporosis and/or Fracture: A Nation-wide Population Based Study

Atrial Fibrillation

Korea, Republic of
University Hospital, Brest

Completed

Extended Duration of Oral Anticoagulant Therapy After a First Episode of Idiopathic Pulmonary Embolism: a Randomized Controlled Trial. "PADIS-PE" Study. (PADIS EP)

Pulmonary Embolism

France
University Hospital, Brest

Completed

Prolonged Anticoagulation After a First Episod of Idiopathic Proximal Deep Vein Thrombosis (PADIS TVP) (PADIS TVP)

Recurrent Venous Thromboembolism | Idiopathic Deep Vein Thrombosis

France
Lundquist Institute for Biomedical Innovation at...

Completed

Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque

Atrial Fibrillation

United States
University of Padova

Completed

Ultrasound Findings to Adjust the Duration of Anticoagulation (AESOPUS)

Deep Vein Thrombosis

Italy
Federal University of São Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil (WARFA)

Atrial Fibrillation

Brazil
Duke University
National Heart, Lung, and Blood Institute (NHLBI); Duke Clinical Research Institute

Terminated

AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis (ACE-IPF)

Idiopathic Pulmonary Fibrosis

United States
Azienda Ospedaliera Universitaria Policlinico

Completed

Absence of Residual Vein Thrombosis Permits to Withdrawn Oral Anticoagulants (Exten-DACUS)

Deep Vein Thrombosis

Italy
Peking Union Medical College Hospital

Unknown

Sirolimus Combined With Low-dose Warfarin for the Treatment of Refractory PNH

Paroxysmal Nocturnal Hemoglobinuria

China
Eli Lilly and Company

Completed

Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants

Healthy Volunteers

United States
National University Hospital, Singapore

Unknown

Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose

Indications for Warfarin Therapy

Singapore, Malaysia
University of Karachi
Advanced Education & Research Center; Karachi Institute of Heart Diseases

Recruiting

Left Atrial Appendage (LAA) Clot With Severe Mitral Stenosis

Left Atrial Appendage Aneurysm | Mitral Stenosis

Pakistan
Jonsson Comprehensive Cancer Center
Novartis Pharmaceuticals

Completed

Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Massachusetts General Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)

Heart Diseases | Cardiovascular Diseases | Cerebrovascular Disorders | Atrial Fibrillation | Arrhythmia | Cerebrovascular Accident | Thrombophlebitis | Cerebral Embolism and Thrombosis
National Taiwan University Hospital

Unknown

The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKOR

Deep Venous Thromboembolism

Taiwan
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Prevention of Recurrent Venous Thromboembolism (PREVENT)

Heart Diseases | Cardiovascular Diseases | Vascular Diseases | Peripheral Vascular Diseases | Thromboembolism | Venous Thromboembolism
Korea University Anam Hospital

Unknown

Short Term Warfarin Therapy for Radiofrequency Catheter Ablation of Atrial Fibrillation

Atrial Fibrillation

Korea, Republic of
Aalborg University Hospital

Completed

Prospective Trial of a Validated Algorithm for Warfarin Dosing

Anticoagulation
Iverson Genetic Diagnostics, Inc.

Suspended

Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN) (WARFARIN)

Atrial Fibrillation | Pulmonary Embolism | DVT | Prosthetic Replacement of Mitral Valve | Anti-coagulation Therapy | Joint Surgery Multiple

United States
Chinese PLA General Hospital

Unknown

Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients

Atrial Fibrillation | Deep Vein Thrombosis | Pulmonary Embolism | Heart Valve Disease

China
China National Center for Cardiovascular Diseases

Completed

Genotype-guided Versus Standard for Warfarin Dosing

Atrial Fibrillation | Valvular Heart Disease

China
Gwen McMillin

Completed

Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin)

Bleeding | Venous Thromboembolism

United States
University of Florida

Withdrawn

PRospective Evaluation Comparing Initiation of Warfarin StrategiEs (PRECISE): Pharmacogenetic-guided Versus Usual Care

Blood Coagulation Disorders

United States
Astellas Pharma Inc

Completed

Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation

Atrial Fibrillation

Taiwan, Japan, Korea, Republic of, New Zealand, Singapore, South Africa, Thailand, Australia, Hong Kong, Malaysia
GlaxoSmithKline

Completed

A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Volunteers

Nausea and Vomiting, Chemotherapy-Induced

United States
AstraZeneca

Completed

Effects of Administration of Fostamatinib on Blood Concentrations of Warfarin in Healthy Subjects

Rheumatoid Arthritis | Healthy Subjects

United Kingdom
Hamilton Health Sciences Corporation

Completed

Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients (FORESPEAK-0)

Myocardial Infarction | Ischemic Stroke | Atrial Fibrillation | Venous Thromboembolism

Canada
Cancer Research Campaign Clinical Trials Centre

Completed

Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters

Thromboembolism

United Kingdom
Academia Sinica, Taiwan
China Medical University Hospital; Chang Gung Memorial Hospital; Kaohsiung Medical...

Completed

Pharmacogenetic Dosing of Warfarin

Stroke | Venous Thrombosis | Atrial Fibrillation | Atrial Flutter

Taiwan
McMaster University
Epitome Pharmaceuticals

Terminated

Randomized Controlled Feasibility Trial of the Fearon Algorithm to Improve Management of Unstable Warfarin

Hypoprothrombinemia

Canada
Eli Lilly and Company

Completed

A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin

Lymphoma, Malignant | Solid Tumor

France

Search clinical trials for: Observational Warfarin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malaysia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations